Bendamustine-containing immunochemotherapy is active in transformed follicular lymphoma with overexpression of p53

Leuk Lymphoma. 2009 Mar;50(3):455-6. doi: 10.1080/10428190802684342.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bendamustine Hydrochloride
  • Female
  • Humans
  • Lymphoma, Follicular / therapy*
  • Nitrogen Mustard Compounds / therapeutic use*
  • Recurrence
  • Remission Induction
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • Nitrogen Mustard Compounds
  • Tumor Suppressor Protein p53
  • Bendamustine Hydrochloride